Latest News & Updates
Other trending news you may like to read
Acurx Expands Global Patent Portfolio With Korea Grant For Novel Antibiotic Platform, Strengthens DNA Polymerase IIIC Inhibitor Program For Resistant Infections
Acurx Pharmaceuticals secures Korea patent for DNA Polymerase IIIC inhibitors, strengthening IP for its antibiotic platform targeting drug-resistant Gram-positive infections and pipeline expansion.
Vaibhavi M.
FDA Approves Biogen’s High-Dose SPINRAZA To Enhance Treatment Outcomes In Spinal Muscular Atrophy
Biogen Inc. gains FDA approval for high-dose SPINRAZA (nusinersen) in spinal muscular atrophy, improving motor function outcomes with an optimized dosing regimen.
Vaibhavi M.
BridgeBio Files FDA NDA For BBP-418, Targets Breakthrough In Muscular Dystrophy Treatment
BridgeBio Pharma submits FDA NDA for BBP-418 targeting limb-girdle muscular dystrophy type 2I/R9, supported by Phase 3 FORTIFY trial results showing strong efficacy outcomes.
Vaibhavi M.
Baxter Showcases IV Verify System To Improve Medication Safety And Nursing Efficiency At Bedside
Baxter International introduces IV Verify system to improve medication safety and nursing efficiency through automated IV labelling, reducing errors in hospital infusion practices.
Vaibhavi M.
